Contineum Therapeutics, Inc. (CTNM) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Contineum Therapeutics, Inc. (CTNM) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

CTNM Income Statement

Contineum Therapeutics, Inc. (CTNM) annual income statement — 5-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q1'23	Q4'22

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	0	0	0	79K	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	-79K	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	100%	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	17.43M	16.9M	17.11M	14.93M	17.82M	18.11M	-84.74M	12.97M	10.94M	9.93M	9.68M	8.07M	5.12M	5.45M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	4.73M	5.26M	4.36M	3.94M	3.84M	4.4M	4.03M	3.25M	3.04M	2.15M	1.66M	1.57M	1.48M	1.5M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	12.7M	11.65M	12.76M	10.99M	13.98M	13.71M	13.02M	9.73M	7.9M	7.78M	8.01M	6.5M	3.63M	3.95M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	-1000K	0	0	0	0	0	0	0
Operating Income	-17.43M	-16.9M	-17.11M	-14.93M	-17.9M	-18.11M	84.74M	-12.97M	-10.94M	-9.93M	-9.68M	-8.07M	-5.12M	-5.45M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	2.65%	6.66%	-120.2%	-15.09%	-63.58%	-82.38%	975.79%	-60.79%	-	-94.13%	-77.57%	-	-	-
EBITDA	-17.29M	-16.82M	-17.03M	-14.85M	-17.82M	-18.03M	84.82M	-12.91M	-10.88M	-9.87M	-9.64M	-8.03M	-5.04M	-5.37M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	2.97%	6.72%	-120.08%	-15.02%	-63.75%	-82.71%	979.93%	-60.88%	-	-95.74%	-79.56%	-	-	-
D&A (Non-Cash Add-back)	134K	83K	85K	81K	79K	78K	75K	62K	60K	61K	37K	43K	73K	81K
EBIT	-17.43M	-16.9M	-17.11M	-12.79M	-16.04M	-15.99M	-14.56M	-10.27M	-9.01M	-8.42M	-7.93M	-6.37M	-4.73M	-7.41M
Net Interest Income	2.34M	2.5M	2.01M	1.96M	2.03M	2.25M	2.53M	2.74M	2M	1.64M	1.79M	1.74M	309K	241K
Interest Income	2.34M	2.5M	2.01M	1.96M	2.03M	2.25M	2.53M	2.74M	2M	1.64M	1.79M	1.74M	401K	342K
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	92K	101K
Other Income/Expense	2.27M	2.45M	1.96M	2.14M	1.86M	2.12M	-99.31M	2.71M	1.94M	1.51M	1.75M	1.7M	291K	-2.06M
Pretax Income	-15.15M	-14.46M	-15.16M	-12.79M	-16.04M	-15.99M	-14.56M	-10.27M	-9.01M	-8.42M	-7.93M	-6.37M	-4.82M	-7.51M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	-161K	-118K	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	2.03%	1.85%	0%	0%
Net Income	-15.15M	-14.46M	-15.16M	-12.79M	-16.04M	-15.99M	-14.56M	-10.27M	-9.01M	-8.42M	-7.77M	-6.25M	-4.82M	-7.51M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	5.52%	9.59%	-4.06%	-24.59%	-78.04%	-89.97%	-87.48%	-64.25%	-	-74.48%	-3.42%	-	-	-
Net Income (Continuing)	-15.15M	-14.46M	-15.16M	-12.79M	-16.04M	-15.99M	-14.56M	-10.27M	-9.01M	-8.42M	-7.77M	-6.25M	-4.82M	-7.51M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.40	-0.39	-0.49	-0.45	-0.62	-0.62	-0.56	-0.40	-0.35	-0.33	-0.05	-0.25	-0.19	-0.30
EPS Growth %	35.48%	37.1%	12.5%	-12.5%	-77.14%	-87.88%	-1078.95%	-60%	-	-73.68%	84.17%	-	-	-
EPS (Basic)	-0.40	-0.39	-0.49	-0.45	-0.62	-0.62	-0.56	-0.40	-0.35	-0.33	-0.05	-0.25	-0.19	-0.30
Diluted Shares Outstanding	37.47M	37.34M	30.86M	28.12M	25.9M	25.87M	25.85M	25.74M	25.72M	25.72M	25.13M	25.13M	25.72M	25.13M
Basic Shares Outstanding	37.47M	37.34M	30.86M	28.12M	25.9M	25.87M	25.85M	25.74M	25.72M	25.72M	25.13M	25.13M	25.72M	25.13M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-